Ligation of CD40 induced tumor necrosis factor-α in rheumatoid arthritis: A novel mechanism of activation of synoviocytes

Journal of Rheumatology

Volumn 26, Issue 5, 1999, Pages 1035-1043

  Harigai, Masayoshi ^a   Hara, Masako ^a   Nakazawa, Satoshi ^a   Fukasawa, Chikako ^a   Ohta, Shuji ^a   Sugiura, Tomoko ^a   Inoue, Kazuhiko ^a   Kashiwazaki, Sadao ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

CD40; Interleukin 1; Rheumatoid arthritis; Tumor necrosis factor

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN GP 39; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADHERENT CELL; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVITIS; SYNOVIUM;

EID: 0032913385     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Ivashkiv LB. Cytokine expression and cell activation in inflammatory arthritis. Adv Immunol 1996;63:337-76.
2. Harris ED. Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
3. Arend W. The pathophysiology and treatment of rheumatoid arthritis. Arthritis Rheum 1997;40:595-97.
4. Firestein G. Invasive fibroblast-like synoviocytes in rheumatoid arthritis: passive responders or transformed aggressors? Arthritis Rheum 1996;39:1781-90.
5. Fox D. The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives. Arthritis Rheum 1997;40:598-609.
6. Burmester G, Stuhmuller B, Keyszer G, et al. Mononuclear phagocytes and rheumatoid synovitis: mastermind or workhorse in arthritis? Arthritis Rheum 1997;40:5-18.
7. Iannone F, Corrigall VM, Kingsley GH, et al. Evidence for the continuous recruitment and activation of T cells into the joints of patients with rheumatoid arthritis. Eur J Immunol 1994;24:2706-13.
8. Hanly JG, Pledger D, Parkhill W, et al. Phenotypic characteristics of dissociated mononuclear cells from rheumatoid synovial membrane. J Rheumatol 1990;17:1274-9.
9. Emery P, Gentry KC, Mackay IR, et al. Deficiency of suppressor inducer subset of T lymphocytes in rheumatoid arthritis. Arthritis Rheum 1987;30:849-56.
10. Calabrese LH, Kelley DM, Myers A, et al. Rheumatic symptoms and human immunodeficiency virus: the influence of clinical and laboratory variables. Arthritis Rheum 1991;34:257-63.
11. Stuyk L, Hawes G, Chatila M, et al. T cell receptors in rheumatoid arthritis. Arthritis Rheum 1995;38:577-89.
12. Gregersen P, Silver J, Winchester R. The shared epitope hypothesis: an approach to understanding the molecule genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
13. Weyand C, McCarthy T, Goronzy JJ. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 1995;95:2120-6.
14. McInnes I, Leung B, Sturrock R, et al. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nature 1997;3:187-95.
15. Klaus S, Pinchuk L, Ochs H, et al. Costimulation through CD40-CD40L interaction. J Immunol 1994;152:5643-52.
16. Clark L, Foy T, Noelle R. CD40 and its ligand. Adv Immunol 1996;63:43-78.
17. Roy M, Waldschmidt T, Aruffo A, et al. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J Immunol 1993;151:2497-510.
18. Saeland S, Duvert V, Moreau I, et al. Human B cell precursors proliferate and express CD23 after CD40 ligation. J Exp Med 1993;178:113-20.
19. Barrett T, Shu G, Clark E. CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells. J Immunol 1991;146:1722-9.
20. Ranheim E, Kipps T. Activated T cells induce expression of B7/BB-1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med 1993;177:925-35.
21. Ranheim E, Kipps T. Tumor necrosis factor-a facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L. Cell Immunol 1995;161:226-35.
22. Roy M, Aruffo A, Ledbetter J, et al. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur J Immunol 1994;25:596-603.
23. Spriggs M, Armitage R, Strockbine L, et al. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 1992;176:1543-50.
24. Valle A, Zuber C, Defrance T, et al. Activation of human B lymphocytes through CD40 and interleukin 4. Eur J Immunol 1989;19:1463-7.
25. Kiener P, Moran-Davis P, Rankin B, et al. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 1995;155:4917-25.
26. Alderson M, Armitage R, Tough T, et al. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993;178:669-74.
27. Wagner DJ, Stout R, Suttles J. Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis. Eur J Immunol 1994;24:3148-54.
28. Kennedy M, Picha K, Fanslow W, et al. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur J Immunol 1996;26:370-8.
29. Tian L, Noelle R, Lawrence D. Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur J Immunol 1995;25:306-9.
30. MacDonald KPA, Nishioka Y, Lipsky PE, et al. Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J Clin Invest 1997;100:2404-14.
31. Arnett FC, Edworthy SM, Bloch DA, et al. American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1987;31:315-24.
32. Fanslow W, Srinivasan S, Paxton R, et al. Structural characteristics of CD40 ligand that determine biological function. Semin Immunol 1994;6:267-78.
33. Harigai M, Hara M, Yoshimura T, et al. Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint disease and its involvement in the cytokine network of rheumatoid synovium. Clin Immunol Immunopathol 1993;69:83-91.
34. Brennan F, Maini R, Feldmann M. Cytokine expression in chronic inflammatory disease. Br Med Bull 1995;51:368-84.
35. Armitage R, Maliszewski C, Alderson M, et al. CD40L: a multi-functional ligand. Semin Immunol 1993;5:401-12.
36. Allen R, Armitage R, Conley M, et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993;259:990-3.
37. Aruffo A, Farrington M, Hollenbaugh D, el al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 1993;72:291-300.
38. Conley M, Larche M, Bonagura V, et al. Hyper IgM syndrome associated with defective CD40-mediated B cell activation. J Clin Invest 1994;4:1404-9.
39. DiSanto J, Bonnefoy J, Gauchat J, et al. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 1993;361:541-3.
40. Fuleihan R, Ramesh N, Loh R, et al. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci USA 1993;90:2170-3.
41. Ramesh N, Fuleihan R, Ramesh V, et al. Deletions in the ligand for CD40 in X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1). Int Immunol 1993;5:769-73.
42. Koyama Y, Tanaka Y, Saito K, et al. Cross-linking of intercellular adhesion molecule 1 (CD54) induces AP-1 activation and IL-1 beta transcription. J Immunol 1996;157:5097-103.
43. Schulze-Koops H, Lipsky P, Kavanaugh A, et al. Persistent reduction in IL-6 mRNA in peripheral blood mononuclear cells of patients with rheumatoid arthritis after treatment with a monoclonal antibody to CD54 (ICAM-1). Clin Exp Immunol 1996;106:190-6.
44. Shakov A, Collart M, Vassali P, et al. κB-type enhancers are involved in LPS-mediated transcriptional activation of the TNF-α gene in primary macrophages. J Exp Med 1990;171:35-42.
45. Yao J, Mackman N, Edgington T, et al. Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by egr-1, c-jun, and NF-κB transcription factors. J Biol Chem 1997;272:17795-801.
46. Rothe M, Sarma V, Dixit V, et al. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 1995;269:1424-7.
47. Watling D, Guschin D, Muller M, et al. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway. Nature 1993;366:166-70.
48. Muller M, Briscoe J, Laxton C, et al. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction. Nature 1993;366:129-35.
49. Burchett SK, Weaver WM, Westall JA, et al. Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes. J Immunol 1988;140:3473-81.
50. Romano MF, Lamberti A, Petrella A, et al. IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes. J Immunol 1996;156:2119-23.
51. Wang P, Wu P, Siegel MI, et al. Interleukin (IL)-10 inhibits nuclear factor kappa B activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 1995;270:9558-63.
52. Grewal I, Flavell R. A central role of CD40 ligand in the regulation of CD4+ T-cell responses. Immunol Today 1996;17:410-4.
53. Linsley P, Clark E, Ledbetter J. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci USA 1990;87:5031-45.
54. Klaus S, Pinchuk L, Ochs H, et al. Costimulation through CD40-CD40L interaction. J Immunol 1994;152:5643-52.
55. Macchia D, Almerigogna F, Parronchi P, et al. Membrane tumor necrosis factor-alpha is involved in the polyclonal B-cell activation induced by HIV-infected T cells. Science 1993;363:464-6.
56. Balsa A, Dixey J, Sansom D, et al. Differential expression of the costimulatory molecules B7.1 (CD80) and B7.2 (Cd86) in rheumatoid synovial tissue. Br J Rheumatol 1996;35:33-7.
57. Liu M, Kohsaka H, Sakuria H, et al. The presence of costimulatory molecules CD86 and CD28 in rheumatoid arthritis synovium. Arthritis Rheum 1996;39:110-4.
58. Harigai M, Kitani A, Hara M, et al. Rheumatoid adherent synovial cells produce B cell differentiation factor activity neutralizable by antibody to B cell stimulatory factor-2/interleukin 6. J Rheumatol 1988;15:1616-22.
59. Rissoan M, Van Kooten C, Chomarat P, et al. The functional CD40 antigen of fibroblasts may contribute to the proliferation of rheumatoid synovium. Clin Exp Immunol 1996;106:481-90.
60. Malik N, Greenfield B, Wahl A, et al. Activation of human monocytes through CD40 induces matrix metalloproteinases. J Immunol 1996;156:3952-60.
61. Datta SK, Kalled SL. CD40-CD40 ligand interaction in autoimmune disease. Arthritis Rheum 1997;40:1735-45.
62. Buhlmann J, Noelle R. Therapeutic potential for blockade of the CD40 ligand, gp39. J Clin Immunol 1996;16:83-9.
63. Durie F, Fava R, Foy T, et al. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 1993;261:1328-30.